Shares of Intuitive Surgical plunged 11% in after-hours trading on October 20, dropping to $390.00 from a $438.00 close, after the robotic surgery giant reported third-quarter results that beat Wall Street estimates on the top and bottom lines — but carried an unwelcome surprise in the fine print. Intuitive Surgical Beats Estimates Across the Board, So Why Did a $450 Million Legal Tab Send Shares Into Free Fall?
Shares of Intuitive Surgical cratered 11% after hours on October 20, dropping to $390 despite a quarter that, on its face, looked like a blowout. Revenue hit $3.05 billion, a 22% jump from $2.51 billion a year earlier , and non-GAAP earnings of $3.00 per share topped the Street's $2.54 estimate by more than 18% . So what spooked investors? A legal settlement — and deeper signs that the company's dominance may be costing it.
• A Half-Billion-Dollar Legal Bill Clouded an Otherwise Clean Quarter. Following mediation in the "da Vinci Surgical Robot Antitrust Litigation" class action, Intuitive agreed — without admitting wrongdoing — to pay a one-time $450 million settlement . After taxes, the charge wiped $347 million, or $0.99 per share, off GAAP earnings , dragging GAAP net income down to $523 million ($1.49/share) from $704 million ($1.95/share) a year ago . Wall Street usually dismisses one-time legal costs, but this one landed alongside a separate Ninth Circuit ruling that revived a different antitrust case challenging Intuitive's control over instrument repair and servicing — raising the question of whether more legal exposure lies ahead.
• Procedure Growth Slowed Even as System Placements Surged. Worldwide procedures grew roughly 15%, with the company's main robotic platform up 14% and its lung-biopsy system up 31% . That sounds healthy, but it marks a deceleration from 16% combined growth in Q2 . Meanwhile, Intuitive placed 546 surgical systems — up from 427 a year earlier — including 315 of its newest model . More robots in hospitals that aren't using them proportionally faster could pressure the per-system economics investors prize.
• A Massive Buyback Couldn't Offset the Anxiety. Intuitive repurchased 7.8 million shares for $2.94 billion in Q3 alone , an aggressive bet by management on its own stock. Yet cash, equivalents, and investments fell to $6.80 billion, a $1.83 billion decline during the quarter — meaning the buyback plus the legal tab consumed a significant portion of its balance sheet. The board had raised its buyback authorization to $5 billion earlier this year , but the runway is now shorter.
• The Stock's Premium Leaves No Room for Surprises. Trading at roughly 50 times trailing earnings entering the report, ISRG was priced for perfection. Shares were already down 25% year-to-date , and the selloff suggests investors are re-evaluating whether even a company growing revenue at 22% can justify that price tag while facing mounting antitrust scrutiny and slowing procedure momentum.